S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:DAWN

Day One Biopharmaceuticals (DAWN) News Today

$13.60
-0.05 (-0.37%)
(As of 06/2/2023 ET)
Compare
Today's Range
$13.26
▼
$13.80
50-Day Range
$11.74
▼
$15.32
52-Week Range
$6.40
▼
$28.35
Volume
761,200 shs
Average Volume
780,267 shs
Market Capitalization
$1.00 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.57
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Get Day One Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter.



DAWN Media Mentions By Week

DAWN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DAWN
News Sentiment
▼
0.34

0.55
▲
Average
Medical
News Sentiment

DAWN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DAWN Articles
This Week
▼
3

3
▲
DAWN Articles
Average Week

SourceHeadline
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Up 4.1%
americanbankingnews.com - June 2 at 6:38 AM
MarketBeat logoHead-To-Head Contrast: Day One Biopharmaceuticals (DAWN) and The Competition
americanbankingnews.com - June 1 at 8:14 AM
finance.yahoo.com logoDay One to Participate in the Goldman Sachs 44th Annual Healthcare Conference
finance.yahoo.com - May 30 at 8:17 AM
baystreet.ca logoPromising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting
baystreet.ca - May 26 at 10:35 AM
marketbeat.com logoCitigroup Inc. Reduces Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
marketbeat.com - May 26 at 5:37 AM
finance.yahoo.com logoCORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - May 26 at 12:34 AM
finance.yahoo.com logoDay One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - May 25 at 7:29 PM
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Sees Strong Trading Volume
americanbankingnews.com - May 24 at 7:46 AM
MarketBeat logoInsider Selling: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CFO Sells $12,529.60 in Stock
americanbankingnews.com - May 20 at 7:52 AM
MarketBeat logoJeremy Bender Sells 3,104 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock
americanbankingnews.com - May 19 at 9:48 AM
msn.com logoHC Wainwright & Co. Reiterates Day One Biopharmaceuticals (DAWN) Buy Recommendation
msn.com - May 18 at 7:27 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Day One Biopharmaceuticals (DAWN)
markets.businessinsider.com - May 18 at 9:26 AM
MarketBeat logoAnalysts Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Target Price at $45.17
americanbankingnews.com - May 17 at 1:34 AM
marketbeat.com logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Analysts
marketbeat.com - May 14 at 1:20 AM
msn.com logoUnusual Put Option Trade in Day One Biopharmaceuticals (DAWN) Worth $116.90K
msn.com - May 9 at 12:50 AM
MarketBeat logoCapital One Financial Weighs in on Day One Biopharmaceuticals, Inc.'s Q2 2023 Earnings (NASDAQ:DAWN)
americanbankingnews.com - May 6 at 2:46 AM
MarketBeat logoEquities Analysts Issue Forecasts for Day One Biopharmaceuticals, Inc.'s FY2027 Earnings (NASDAQ:DAWN)
americanbankingnews.com - May 5 at 4:28 AM
MarketBeat logoDay One Biopharmaceuticals, Inc. Expected to Earn Q1 2024 Earnings of ($0.59) Per Share (NASDAQ:DAWN)
americanbankingnews.com - May 5 at 3:55 AM
MarketBeat logoQ2 2023 Earnings Estimate for Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Issued By HC Wainwright
americanbankingnews.com - May 4 at 7:30 AM
MarketBeat logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) to Post Q2 2023 Earnings of ($0.58) Per Share, Wedbush Forecasts
americanbankingnews.com - May 4 at 7:30 AM
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Up 10.3%
americanbankingnews.com - May 3 at 6:40 AM
msn.com logoNeedham Reiterates Day One Biopharmaceuticals (DAWN) Buy Recommendation
msn.com - May 2 at 6:54 PM
markets.businessinsider.com logoNeedham Reaffirms Their Buy Rating on Day One Biopharmaceuticals (DAWN)
markets.businessinsider.com - May 2 at 1:54 PM
markets.businessinsider.com logoPiper Sandler Keeps Their Buy Rating on Day One Biopharmaceuticals (DAWN)
markets.businessinsider.com - May 2 at 8:54 AM
MarketBeat logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Up 6.1% in April
americanbankingnews.com - May 2 at 5:50 AM
finance.yahoo.com logoDay One Reports First Quarter 2023 Financial Results and Corporate Progress
finance.yahoo.com - May 1 at 9:56 AM
MarketBeat logoBank of America Downgrades Day One Biopharmaceuticals (NASDAQ:DAWN) to Underperform
americanbankingnews.com - April 27 at 3:00 AM
finance.yahoo.com logoDay One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - April 26 at 1:13 PM
msn.com logoB of A Securities Downgrades Day One Biopharmaceuticals (DAWN)
msn.com - April 25 at 8:45 PM
msn.com logoDay One Biopharma falls 14% as Bank of America downgrades
msn.com - April 25 at 10:44 AM
markets.businessinsider.com logoWhat 5 Analyst Ratings Have To Say About Day One Biopharmaceutical
markets.businessinsider.com - April 25 at 10:44 AM
MarketBeat logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $43.57 Consensus Target Price from Analysts
americanbankingnews.com - April 22 at 1:38 AM
finance.yahoo.com logoLeaked: Apple's Secret Health Play Could Push Out Smaller Apps
finance.yahoo.com - April 21 at 5:45 PM
finance.yahoo.com logoA Daily Journal For iPhone: Apple Weighs Day One-Like Health App For iPhone Users
finance.yahoo.com - April 21 at 12:44 PM
markets.businessinsider.com logoJonesTrading Keeps Their Buy Rating on Day One Biopharmaceuticals (DAWN)
markets.businessinsider.com - April 20 at 12:52 PM
MarketBeat logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Sees Large Growth in Short Interest
americanbankingnews.com - April 20 at 7:34 AM
marketbeat.com logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - April 19 at 2:19 AM
finance.yahoo.com logoDay One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
finance.yahoo.com - April 12 at 8:52 AM
finance.yahoo.com logoDay One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
finance.yahoo.com - April 12 at 8:52 AM
seekingalpha.com logoDay One Biopharmaceuticals: Strong Potential, Price Drop Opportunity, Some Concerns
seekingalpha.com - April 7 at 7:37 AM
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $44.00
americanbankingnews.com - April 7 at 3:58 AM
msn.com logoAnalyst Expectations for Day One Biopharmaceutical's Future
msn.com - April 5 at 5:56 PM
msn.com logoNeedham Maintains Day One Biopharmaceuticals (DAWN) Buy Recommendation
msn.com - April 5 at 5:56 PM
MarketBeat logoDay One Biopharmaceuticals, Inc. Forecasted to Post FY2023 Earnings of ($2.66) Per Share (NASDAQ:DAWN)
americanbankingnews.com - April 2 at 1:52 AM
marketbeat.com logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) to Post FY2023 Earnings of ($2.66) Per Share, Oppenheimer Forecasts
marketbeat.com - March 31 at 6:51 AM
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase
americanbankingnews.com - March 29 at 5:34 AM
MarketBeat logoBrokerages Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Target Price at $44.14
americanbankingnews.com - March 28 at 2:20 AM
nasdaq.com logoDay One Biopharmaceuticals Becomes Oversold (DAWN)
nasdaq.com - March 26 at 12:12 AM
marketbeat.com logoDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - March 25 at 2:17 AM
MarketBeat logoDay One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 4.5%
americanbankingnews.com - March 24 at 7:40 AM
Get Day One Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:DAWN) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -